Integral Molecular Announces Patent Allowance for Dengue Research Technology

July 17, 2014 Integral Molecular, a leader in membrane protein research, announces the issuance of a new composition patent protecting dengue reporter virus particles (RVPs). The invention relates to the company’s chimeric and codon-optimized flavivirus replicons, expression plasmids, and RVPs used for infectivity, neutralization, enhancement and structure-function studies of dengue virus (DENV) and its envelope protein (prM/E). U.S. Patent No …

Braasch Biotech Continues to Build Patent Portfolio With Acceptances in the European Union, Russia and Israel

April 28, 2014 Braasch Biotech LLC, a biopharmaceutical company developing and commercializing anti-somatostatin vaccines, today announced that it has received Notices of Acceptance from the European, Russian and Israeli Patent Offices for a patent covering the use of Braasch’s product candidate, JH14-Somatovac®. The vaccine is indicated for use in farmed animals and safely enhances the target animal’s own ability to produce …

PD-1 Gene Expression Profiles for Drug Development US Patent Awarded to Vaccine and Gene Institute Florida Scientists

March 2, 2014 The Vaccine and Gene Institute of Florida (VGTI Florida) announced today that the US Patent and Trademark Office awarded VGTI Florida scientists Dr. Rafick-Pierre Sékaly, PhD and Dr. Elias Haddad, PhD U.S. Patent No. 8,647,822 titled ‘Determining whether a test compound modulates PD-1 activity in activated immune cells using gene expression profiles.’ The PD-1 pathway (programmed cell …

iBio Receives Patent Allowances for Pandemic Influenza Therapeutics

March 27, 2014 iBio, Inc., a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance of two U.S. patents for monoclonal antibodies targeting influenza. “The antibodies covered by these patents are designed to block critical functions of the influenza virus necessary for infection or replication,” said Wayne P. Fitzmaurice, Ph.D., iBio’s vice president of intellectual property. …

Dispute erupts over novel coronavirus patent claims

A dispute has erupted between leading research scientists and international health officials, following a declaration by Saudi Arabia's deputy health minister that the country had struggled to develop diagnostic tests for the novel coronavirus because the Dutch scientists who identified it had patented the virus outside of the country. According to Reuters, deputy health minister Ziad Memish told the World …